Literature DB >> 21314784

Relationship between B-type natriuretic peptide and adverse outcome in patients with clinical evidence of sepsis presenting to the emergency department.

Sarah M Perman1, Anna Marie Chang, Judd E Hollander, David F Gaieski, Stephen Trzeciak, Robert Birkhahn, Ronny Otero, Tiffany M Osborn, Eugene Moretti, H Bryant Nguyen, Kyle J Gunnerson, David Milzman, Munish Goyal, Charles B Cairns, Long Ngo, Emanuel P Rivers, Nathan I Shapiro.   

Abstract

OBJECTIVES: Myocardial dysfunction is an important aspect of sepsis pathophysiology. B-type natriuretic peptide (BNP) is a neurohormone released from the ventricles in response to myocardial stretch and volume overload. The authors hypothesized that an elevated BNP in patients presenting to the emergency department (ED) with suspected sepsis are at increased risk for development of adverse events.
METHODS: This was a prospective, observational, multicenter cohort study in 10 EDs. Patients were eligible if they were older than 18 years, had two or more systemic inflammatory response syndrome (SIRS) criteria, and had suspected infection or a serum lactate level > 2.5 mmol/L. Patients were excluded if they were pregnant, had do-not-attempt-resuscitation status, sustained a cardiac arrest prior to hospital arrival, had known chronic renal insufficiency, or were on dialysis. BNP levels were obtained at arrival. The primary outcome was a composite of severe sepsis, septic shock within 72 hours, or in-hospital mortality.
RESULTS: There were 825 patients enrolled (mean ± standard deviation [SD] age = 53.5 ± 19.6 years; 51% were female and 37% were African American). The area under the curve (AUC) for BNP to predict the triple composite outcome was 0.69, and the optimal cut-point of BNP was 49 pg/mL. Patients with a BNP > 49 pg/mL had a greater mortality rate (11.6% vs. 2.1%; p = 0.0001), a greater risk of development of severe sepsis (67.7% vs. 36.8%; p = 0.0001) and septic shock (51.7% vs. 26.4%; p = 0.0001), and a higher rate of the triple composite outcome (69% vs. 37%; unadjusted odds ratio [OR] = 1.9, 95% confidence interval [CI] = 1.6 to 2.1; p < 0.001). The sensitivity was 63% (95% CI = 58% to 67%), specificity was 69% (95% CI = 65% to 73%), negative predictive value (NPV) was 63% (95% CI = 58% to 67%), and positive predictive value (PPV) was 69% (95% CI = 65% to 74%). In multivariate modeling, after adjusting for age, sex, heart rate, white blood cell count, and creatinine, an elevated BNP was associated with increased odds of having the composite outcome. The outcome was similar in the subset of patients who did not have severe sepsis or septic shock upon arrival.
CONCLUSIONS: In patients who present to the ED with SIRS criteria and suspected infection, an elevated BNP is associated with a worse prognosis but has limited diagnostic utility.
© 2011 by the Society for Academic Emergency Medicine.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21314784     DOI: 10.1111/j.1553-2712.2010.00968.x

Source DB:  PubMed          Journal:  Acad Emerg Med        ISSN: 1069-6563            Impact factor:   3.451


  17 in total

Review 1.  Are there new approaches for diagnosis, therapy guidance and outcome prediction of sepsis?

Authors:  Dubravka Kojic; Benedikt H Siegler; Florian Uhle; Christoph Lichtenstern; Peter P Nawroth; Markus A Weigand; Stefan Hofer; Thorsten Brenner
Journal:  World J Exp Med       Date:  2015-05-20

2.  Inflammation and Circulating Natriuretic Peptide Levels.

Authors:  Hannah Fish-Trotter; Jane F Ferguson; Nirav Patel; Pankaj Arora; Norrina B Allen; Katherine N Bachmann; Lori B Daniels; Muredach P Reilly; Joao A C Lima; Thomas J Wang; Deepak K Gupta
Journal:  Circ Heart Fail       Date:  2020-06-08       Impact factor: 8.790

3.  Complete Blood Count and Myocardial Markers Combination with Sequential Organ Failure Assessment Score Can Effectively Predict the Mortality in Sepsis: A Derivation and Validation Study.

Authors:  An Zhang; Pengfei Wang; Keli Wen; Hu Du; Binfei Tang; Bin Xiong
Journal:  Int J Gen Med       Date:  2022-03-23

4.  Sensitivity of systemic inflammatory response syndrome for critical illness among ED patients.

Authors:  Michael M Liao; Dennis Lezotte; Steven R Lowenstein; Kevin Howard; Zachary Finley; Zipei Feng; Richard L Byyny; Jeffrey D Sankoff; Ivor S Douglas; Jason S Haukoos
Journal:  Am J Emerg Med       Date:  2014-08-08       Impact factor: 2.469

5.  Myocardial dysfunction in sepsis: a large, unsolved puzzle.

Authors:  Constantino Jose Fernandes; Murillo Santucci Cesar de Assuncao
Journal:  Crit Care Res Pract       Date:  2012-03-13

6.  Prognostic value of B-type natriuretic peptide (BNP) and its potential role in guiding fluid therapy in critically ill septic patients.

Authors:  Zhongheng Zhang; Zhengguang Zhang; Yadong Xue; Xiao Xu; Hongying Ni
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2012-12-31       Impact factor: 2.953

Review 7.  Brain natriuretic peptide for prediction of mortality in patients with sepsis: a systematic review and meta-analysis.

Authors:  Fei Wang; Youping Wu; Lu Tang; Weimin Zhu; Feng Chen; Tao Xu; Lulong Bo; Jinbao Li; Xiaoming Deng
Journal:  Crit Care       Date:  2012-05-06       Impact factor: 9.097

8.  Cystatin C in a composite risk score for mortality in patients with infective endocarditis: a cohort study.

Authors:  Christian Bjurman; Ulrika Snygg-Martin; Lars Olaison; Michael L X Fu; Ola Hammarsten
Journal:  BMJ Open       Date:  2012-07-12       Impact factor: 2.692

9.  N-terminal pro-brain-type natriuretic peptide (NT-pro-BNP) and mortality risk in early inflammatory polyarthritis: results from the Norfolk Arthritis Registry (NOAR).

Authors:  Hoda Mirjafari; Paul Welsh; Suzanne M M Verstappen; Paddy Wilson; Tarnya Marshall; Helena Edlin; Diane Bunn; Jacqueline Chipping; Mark Lunt; Deborah P M Symmons; Naveed Sattar; Ian N Bruce
Journal:  Ann Rheum Dis       Date:  2013-03-19       Impact factor: 19.103

Review 10.  The role of natriuretic peptides for the diagnosis of left ventricular dysfunction.

Authors:  Alberto Palazzuoli; Matteo Beltrami; Gaetano Ruocco; Marco Pellegrini; Ranuccio Nuti
Journal:  ScientificWorldJournal       Date:  2013-09-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.